Abstract
It is frequent to see pulmonary hypertension (PH) in patients with mitral stenosis (MS) secondary to increased pulmonary vascular resistance (PVR), data about the effect of PVR on the results of percutaneous balloon mitral valvotomy (PBMV) are insufficient. To detect the role of PVR in predicting residual PH immediately after PBMV. This prospective study comprised 49 consecutive patients with moderate to severe MS who were investigated pre and within 48 h post a successful PBMV for the first time. Echocardiography was used to assess the mitral valve area (MVA), mean transmitral pressure gradient (MPG), mitral valve resistance (MVR), right ventricular systolic pressure (RVSP) and PVR. Patients were classified into two groups according to the pre PVR (≥ 1.6 WU as group I and < 1.6 as group II). At baseline compared to group II (32 patients), Group I (17 patients) had higher MPG (13.6 ± 5.2 vs. 11.7 ± 3.7 mmHg, P < 0.05), RVSP (45.6 vs. 37.9 mmHg, P < 0.001) and PVR (2.2 ± 0.1 vs. 1.2 ± 0.1WU, P < 0.001) with no significant difference regarding age, gender, MVS, MVA and MVR. Patients of group I had comparatively lower improvement immediate post procedural of RVSP and PVR with no significant difference in immediate post procedural improvement in NYHA classification, MVA, MPG and MVR. Basal PVR > 1.8WU was proved to be a highly specific (91%), a good predictor (AUC 0.78) of persistent elevation of RVSP > 50 mmHg post PMV. Pathological rise of PVR that associates MS had provided a strong and an independent predictor of persistent pulmonary hypertension post PBMV and by this aspect it could be used as a valuable tool as MVA and MPG to send patients earlier for PBMV even with less severe MS. PVR > 1.81 WU could be used as a noninvasive parameter for predicting regression of PH immediately after PBMV.
Similar content being viewed by others
References
Farrag AAM, El-Aroussy W, EL-Hagracy N, Fawzy H, Taha N, Moustafa S (2014) PM472 Echocardiographic screening for rheumatic valvular heart disease among Egyptian school children. Global Heart 9(1):e158-9
Shiran A, Sagie A (2009) Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol 53(5):401–408
Shrestha N, Dev Bhatta YK, Maskey A, Malla R, Rajbhandari R, Kansakar S, Sharma R, Adhikari CM, Prajapati D, Kesavan S, Shrestha S (2015) Immediate outcome of percutaneous balloon mitral valvotomy in Shahid Gangalal National Heart Centre, Bansbari, Kathmandu, Nepal. Nepalese Heart J 12(1):11–14
Garbarz E, Iung B, Cormier B, Vahanian A (1999) Echocardiographic criteria in selection of patients for percutaneous mitral commissurotomy. Echocardiography 16(7 Pt 1):711–721
Krishnamoorthy KM, Dash PK, Radhakrishnan S, Shrivastava S (2002) Response of different grades of pulmonary artery hypertension to balloon mitral valvuloplasty. Am J Cardiol 90(10):1170–1173
Harikrishnan S, Kartha CC (2009) Pulmonary hypertension in rheumatic heart disease. PVRI Rev 1:13–19
Mandal I (2017) Pulmonary hypertension before and after balloon mitral Valvuloplasty. Int J Med Res Rev 5(03):279–284
Nishimura RA, Carabello BA (2012) Contemporary reviews in cardiovascular medicine hemodynamics in the cardiac catheterization laboratory of the 21st century. Circulation 125(17):2138–2150
Bech-Hanssen O, Karason K, Rundqvist B, Bollano E, Lindgren F, Selimovic N (2013) Can pulmonary hypertension and increased pulmonary vascular resistance be ruled in and ruled out by echocardiography? J Am Soc Echocardiogr 26(5):469–478
Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M (2009) Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10(1):1–25
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Writing Committee Members; American College of Cardiology/American Heart Association Task Force (2006) 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): endorsed by the society of cardiovascular anesthesiologists. Society for cardiovascular angiography and interventions, and society of thoracic surgeons. Circulation 118(15):e523-661
Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IF (1988) Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J 60(4):299–308
Izgi C, Ozdemir N, Cevik C, Ozveren O, Bakal RB, Kaymaz C, Ozkan M (2007) Mitral valve resistance as a determinant of resting and stress pulmonary artery pressure in patients with mitral stenosis: a dobutamine stress study. J Am Soc Echocardiogr 20(10):1160–1166
Kircher BJ, Himelman RB, Schiller NB (1990) Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66(4):493–496
Abbas AE, Franey LM, Marwick T, Maeder MT, Kaye DM, Vlahos AP, Serra W, Al-Azizi K, Schiller NB, Lester SJ (2013) Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr 26(10):1170–1177
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Task force for diagnosis and treatment of pulmonary hypertension of European society of cardiology (ESC); European respiratory society (ERS); International society of heart and lung transplantation (ISHLT). Eur Respir J 34(6):1219–1263
Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Task force for diagnosis and treatment of pulmonary hypertension of European society of cardiology (ESC); European respiratory society (ERS); International society of heart and lung transplantation (ISHLT). Eur Heart J 30:2493–2537
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease. J Am Coll Cardiol 63(22):e57–e185
Fawzy ME, Osman A, Nambiar V, Nowayhed O, El DA, Badr A, Canver CC (2008) Immediate and long-term effects of mitral balloon valvotomy on severe pulmonary hypertension. J Heart Valve Dis 17(5):485–491
Dev V, Shrivastava S (1991) Time course of changes in pulmonary vascular resistance and the mechanism of regression of pulmonary arterial hypertension after balloon mitral valvuloplasty. Am J Cardiol 67:439–442
Nair KK, Pillai HS, Titus T, Varaparambil A, Sivasankaran S, Krishnamoorthy KM, Namboodiri N, Sasidharan B, Thajudeen A, Ganapathy S, Tharakan J (2013) Persistent pulmonary artery hypertension in patients undergoing balloon mitral valvotomy. Pulm Circ 3(2):426–431
Siahaan IH, Kasim M, Soesanto AM, Harimurti GM (2008) Persistence pulmonal hypertension after balloon mitral valvuloplasty. J Kardiol Indones 29:107–116
Ribeiro PA, Al Zaibag M, Abdullah M (1993) Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis. Am Heart J 125:1110–1114
Fawzy ME, Hegazy H, Shoukri M, El Shaer F, ElDali A, Al-Amri M (2005) Long-term clinical and echocardiographic results after successful mitral balloon valvotomy and predictors of long-term outcome. Eur Heart J 26(16):1647–1652
Krishnamoorthy KM, Dash PK, Radhakrishnan S, Shrivastava S (2002) Response of different grades of pulmonary artery hypertension to balloon mitral valvuloplasty. Am J Cardiol 90:1170–1173
Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA (2004) Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 13:942–947
Burger W, Illert S, Teupe C, Kneissl GD, Kober G, Schräder R (1993) Right ventricular function in patients with rheumatic mitral valve stenosis. Effect of balloon mitral Valvuloplasty. Z Kardiol 82(9):545–551
Fawzy ME (2014) Mitral balloon valvotomy, long-term results, its impact on severe pulmonary hypertension, tricuspid regurgitation, atrial fibrillation, left atrial size, left ventricular function. Egypt Heart J 66(2):133–138
Pan M, Medina A, Suarez de Lezo J, Romero M, Romero M, Hernandez E, Segura J, Melian F, Pavlovic D, Jimenez F, Vivancos R (1991) Balloon valvuloplasty for mild mitral stenosis. Cathet Cardiovasc Diagn 24:1–5
Chen ZQ, Hong L, Wang H, Lu LX, Yin QL, Lai HL, Li HT, Wang X (2015) Application of percutaneous balloon mitral valvuloplasty in patients of rheumatic heart disease mitral stenosis combined with tricuspid regurgitation. Chin Med J 128:1479–1482
Acknowledgements
To all colleagues in cardiology department who helped us to end this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Elmaghawry, L.M., El-Dosouky, I.I., Kandil, N.T. et al. Pulmonary vascular resistance and proper timing of percutaneous balloon mitral valvotomy. Int J Cardiovasc Imaging 34, 523–529 (2018). https://doi.org/10.1007/s10554-017-1255-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-017-1255-3